Evidence map›Paper›PMID 37524878›Full record

ArticleExperimental & molecular medicine2023

Dysregulation of the Wnt/β-catenin signaling pathway via Rnf146 upregulation in a VPA-induced mouse model of autism spectrum disorder.

Gaeun Park, Wooyoung Eric Jang, Seoyeon Kim, Edson Luck Gonzales, Jungeun Ji, Seunghwan Choi, Yujin Kim, Ji Hwan Park, Hazara Begum Mohammad, Geul Bang and 9 more

Open access · goldAbstract read
In one paragraph

Article in Experimental & molecular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Serum Levels of Wnt/β-catenin Pathway Regulators Dkk-1, PORCN, Notum, and Tiki-1 in Children with Autism Spectrum Disorder.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Case Report: A novelFrontiers in psychiatry · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 4 countries.

Gaeun Park *Department of Biomedical Science, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
Wooyoung Eric Jang *Department of Applied Chemistry, Institute of Natural Science, Global Center for Pharmaceutical Ingredient Materials, Kyung Hee University, Yongin, 17104, Republic of Korea.
Seoyeon Kim *Department of Integrated Biomedical and Life Science, Korea University, Seoul, 02841, Republic of Korea.
Edson Luck GonzalesSchool of Medicine and Center for Neuroscience Research, Konkuk University, Seoul, 05029, Republic of Korea.
Jungeun JiDepartment of Integrated Biomedical and Life Science, Korea University, Seoul, 02841, Republic of Korea.
Seunghwan ChoiSchool of Biosystem and Biomedical Science, College of Health Science, Korea University, Seoul, 02841, Republic of Korea.
Yujin KimDepartment of Integrated Biomedical and Life Science, Korea University, Seoul, 02841, Republic of Korea.
Ji Hwan ParkDepartment of New Biology, DGIST, Daegu, 42988, Republic of Korea.
Hazara Begum MohammadDepartment of New Biology, DGIST, Daegu, 42988, Republic of Korea.
Geul BangResearch Center for Bioconvergence Analysis, Korea Basic Science Institute, Ochang, 28119, Republic of Korea.
Minkyung KangDepartment of Biomedical Science, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
Soobin KimDepartment of Biomedical Science, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
Se Jin JeonSchool of Medicine and Center for Neuroscience Research, Konkuk University, Seoul, 05029, Republic of Korea.
Jin Young KimResearch Center for Bioconvergence Analysis, Korea Basic Science Institute, Ochang, 28119, Republic of Korea.ORCID http://orcid.org/0000-0002-0656-1269
Kwang Pyo KimDepartment of Applied Chemistry, Institute of Natural Science, Global Center for Pharmaceutical Ingredient Materials, Kyung Hee University, Yongin, 17104, Republic of Korea.
Chan Young ShinSchool of Medicine and Center for Neuroscience Research, Konkuk University, Seoul, 05029, Republic of Korea. chanyshin@kku.ac.kr.
Joon-Yong AnDepartment of Integrated Biomedical and Life Science, Korea University, Seoul, 02841, Republic of Korea. joonan30@korea.ac.kr.ORCID http://orcid.org/0000-0001-8839-6297
Min-Sik KimDepartment of New Biology, DGIST, Daegu, 42988, Republic of Korea. mkim@dgist.ac.kr.ORCID http://orcid.org/0000-0001-7317-5360
Yong-Seok LeeDepartment of Biomedical Science, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea. yongseok7@snu.ac.kr.ORCID http://orcid.org/0000-0002-6217-9574
Seoul National University · KRKorea University · KRDaegu Gyeongbuk Institute of Science and Technology · KRKonkuk University · KRKorea Basic Science Institute · KRKyung Hee University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autism spectrum disorder (ASD) is a neurodevelopmental disorder associated with impaired social behavior and communication, repetitive behaviors, and restricted interests. In addition to genetic factors, environmental factors such as prenatal drug exposure contribute to the development of ASD. However, how those prenatal factors induce behavioral deficits in the adult stage is not clear. To elucidate ASD pathogenesis at the molecular level, we performed a high-resolution mass spectrometry-based quantitative proteomic analysis on the prefrontal cortex (PFC) of mice exposed to valproic acid (VPA) in utero, a widely used animal model of ASD. Differentially expressed proteins (DEPs) in VPA-exposed mice showed significant overlap with ASD risk genes, including differentially expressed genes from the postmortem cortex of ASD patients. Functional annotations of the DEPs revealed significant enrichment in the Wnt/β-catenin signaling pathway, which is dysregulated by the upregulation of Rnf146 in VPA-exposed mice. Consistently, overexpressing Rnf146 in the PFC impaired social behaviors and altered the Wnt signaling pathway in adult mice. Furthermore, Rnf146-overexpressing PFC neurons showed increased excitatory synaptic transmission, which may underlie impaired social behavior. These results demonstrate that Rnf146 is critical for social behavior and that dysregulation of Rnf146 underlies social deficits in VPA-exposed mice.

Indexed as

Autism Spectrum DisorderUbiquitin-Protein LigasesWnt Signaling PathwayAnimalsDisease Models, AnimalFemaleMicePregnancyProteomicsUp-RegulationValproic AcidRnf146 protein, mouseUbiquitin-Protein LigasesValproic Acid

Identifiers

PMID37524878
PMCPMC10474298
OpenAlexW4385407998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.